The MarkeTech Group (TMTG) conducted a poll of its imagePRO opt-in panel of more than 600 U.S.-hospital based imaging administrative directors and managers. Manuel Andrade, TMTG's reserach analyst, made the analysis.
Q: What is the likelihood that extended reimbursement for PET-FDG will prompt your institution to purchase new or additional PET/CT system(s) in the next 18 months?
A: Respondents are uncertain if reimbursements will prompt new or additional PET/CT units purchases.
January 23, 2024 — Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of syngo Virtual ...
January 23, 2024 
January 23, 2024 — Quibim announced it has added an industry-leading cancer detection capability to its prostate tool ...
January 22, 2024 
December 27, 2023 — The American Roentgen Ray Society (ARRS) announced David M. Naeger, MD, as the 2024 ARRS ...
December 27, 2023 
December 6, 2023 — Philochem AG, a wholly owned subsidiary of Philogen S.p.A., and Blue Earth Diagnostics, a Bracco ...
December 06, 2023 
November 30, 2023 — Through its leading imaging solutions and commitment to innovation, GE HealthCare remains at the ...
November 30, 2023 
November 25, 2023 — Mirion announced that it will debut the new Instadose VUE personal dosimeter, from its Dosimetry ...
November 25, 2023 
November 22, 2023 — Siemens Healthineers has announced the U.S. Food and Drug Administration (FDA) clearance of the ...
November 22, 2023 
October 11, 2023 — A new imaging agent, 68Ga-ABY-025, can predict early metabolic response to human epidermal growth ...
October 11, 2023 
September 21, 2023 — Scientists in Moscow have successfully engineered a prototype detector for X-ray and PET/CT ...
September 21, 2023 
August 15, 2023 — In elderly patients with suspected prostate cancer, PSMA PET/CT can diagnose advanced disease and aid ...
August 15, 2023